The mouse int6 gene is a frequent integration site of the mouse mammary tumor virus and INT6 silencing by RNA interference in HeLa cells causes an increased number of cells in the G2/M phases of the cell cycle, along with mitotic defects. In this report, we investigated the functional significance of the interaction between INT6 and MCM7, which was observed in a two-hybrid screen performed with INT6 as bait. It was found that proteasome inhibition strengthens interaction between both proteins and that INT6 stabilizes MCM7. Removal of MCM7 from chromatin as replication proceeds was accelerated in INT6-silenced cells and reduced amounts of protein were transiently observed, followed by a correction resulting from stimulation of mcm7 gene expression. Synchronized cells depleted for either INT6 or MCM7 display a reduction in thymidine incorporation and a reinforced association of RPA and claspin with chromatin. These data show that INT6 stabilizes chromatin-bound MCM7 and that alteration of this effect is associated with replication deficiency.
Introduction
The int6 gene was first identified as a frequent integration site of the MMTV virus in preneoplastic and neoplastic mammary lesions (Marchetti et al., 1995) . Viral insertion might lead to int6 haploinsufficiency or to production of C-terminally truncated proteins. Overexpression of such INT6-truncated forms was found to transform murine and human cell lines (Rasmussen et al., 2001; Mayeur and Hershey, 2002 ). Moreover, int6 mRNA level is decreased in 27% of nonsmall cell lung carcinomas and this event represents a predictor of poor prognosis (Buttitta et al., 2005) . However, molecular basis of cellular transformation resulting from INT6 alteration remains so far ill defined. INT6 has been characterized as an eIF3 translation initiation factor subunit in rabbit (Asano et al., 1997) , Schizosaccharomyces pombe (Bandyopadhyay et al., 2000; Crane et al., 2000; Akiyoshi et al., 2001) and Arabidopsis Thaliana (Burks et al., 2001; Yahalom et al., 2001) , but evidence of its functional role in eIF3 is lacking. A study in fission yeast showed that disruption of the INT6 homolog (Yin6) triggers a reduction in polysome content (Akiyoshi et al., 2001 ) but this has not been confirmed by others (Zhou et al., 2005) . Moreover, in contrast to other eIF3 subunits, suppression of Yin6 marginally affects overall translation efficiency (Bandyopadhyay et al., 2000; Zhou et al., 2005) . Several other observations indicate a role of INT6 in protein degradation. Indeed INT6, which includes a protein domain shared by several subunits of the lid of the proteasome 19S regulatory particle, of the COP9 signalosome (CSN) and of eIF3, and thereafter named PCI, is known to interact with both the 26S proteasome and the CSN (Hoareau Alves et al., 2002) . In A. thaliana, INT6 is predominantly nuclear and associated with CSN in root cells, but cytoplasmic and associated with eIF3 in leaf cells (Yahalom et al., 2001) . In fission yeast, Yin6 enables proteasome activity by promoting the nuclear import of its Rpn5 subunit, and Yin6 inactivation causes defective cyclin B and securin degradation, leading to mitotic anomalies (Yen and Chang, 2000; Yen et al., 2003) . In human cells, we showed that INT6 silencing also leads to mitosis alteration due to defects in spindle formation, chromosome segregation and cytokinesis (Morris and Jalinot, 2005) .
As a two-hybrid screen with INT6 as bait led to isolation of the MCM7 DNA replication licensing factor, a possible role of the disruption of the normal MCM7 functioning following INT6 silencing was explored. MCM7 is a subunit of the MCM complex (MCM2-7) that plays a key role in DNA replication licensing. Replication origins are competent or 'licensed' to initiate replication only once per cell cycle by recruiting during late mitosis and G1 the MCM complex. This recruitment depends on ORCs, Cdc6 and Cdt1 proteins (Gillespie et al., 2001; Yanagi et al., 2002; Cook et al., 2004) . In the course of replication, MCMs dissociate from DNA and re-association cannot occur before the next cell division. Besides its role in replication initiation, MCM7 is necessary for the helicase activity of the MCM complex. Indeed, the mammalian MCM4,6,7 sub-complex, purified from cultured cells (Ishimi, 1997) or reconstituted with recombinant proteins (Lee and Hurwitz, 2001 ) exerts in vitro an helicase activity that requires the MCM7 ATPase motifs .
We show here that INT6 interacts with polyubiquitylated forms of MCM7 and that INT6 silencing destabilizes this replication factor during S phase. Conversely, INT6 overexpression stabilizes MCM7 and increases the amount of its polyubiquitylated forms on chromatin. From the data presented in this report, we propose that INT6 contributes to the replication process by protecting MCM7 from degradation during S phase.
Results

INT6 interacts with the MCM7 subunit of the MCM complex
A library of cDNAs prepared from human lymphocytes immortalized with EBV (Durfee et al., 1993) was screened by the two-hybrid method using INT6 fused to the GAL4 DNA-binding domain as bait. This led to isolation of partial cDNAs encoding the p110 subunit of eIF3 and Rfp, as reported previously (Morris-Desbois et al., 1999) , but also to clones corresponding to the C-terminal part of MCM7, the shortest one encoding the C-terminal 205 amino acids of the protein (Figure 1a) . The MCM7 region encoded by the three clones was located 3 0 to the MCM box, which is highly conserved among the various MCMs (Figure 1a) . Interaction between INT6 and the protein expressed by the largest MCM7 clone was observed to cause a clear expression of the b-galactosidase reporter gene in a liquid culture assay (Figure 1b) , although weaker than that resulting from the interaction of INT6 with either eIF3 p110 or the viral Tax protein encoded by HTLV-I (Desbois et al., 1996) . These observations suggested that INT6 might associate with MCM7 in human cells. This was tested by cotransfecting 293T cells with vectors expressing MCM7 tagged at its N-terminus by the MYC epitope, and INT6 fused to the FLAG tag at its C-terminus in order to preserve the N-terminal NES (Guo and Sen, 2000) . Precipitation of INT6 using the antibody to FLAG was found to bring down MCM7 and conversely INT6 was coprecipitated when MCM7 was pulled down with the antibody to the MYC epitope ( Figure 1c, lane 8) . We next tested whether interaction occurred between endogenous proteins. Extracts of Jurkat (Figure 1d , lanes 1-3) and HeLa cells (Figure 1d , lanes 4-6) were immunoprecipitated with an antibody directed against INT6 or the corresponding preimmune serum. Immunoblot analysis of MCM7 revealed that the protein which appears as a double band was clearly coprecipitated with INT6 in both cell types, although slightly more efficiently in Jurkat (Figure 1d , compare lanes 2 and 5), showing that the interaction occurs between endogenous proteins.
To determine which part of INT6 is required for binding MCM7, the two-hybrid assay was used with MCM7 fused to the GAL4 DNA binding domain as bait and INT6 deleted either on the N-terminal or Cterminal side fused to the GAL4-activation domain. At the C-terminus, removal of amino acids 395-331 led to loss of the binding of INT6 to MCM7 (Figure 1e ). On the other hand, each construct deleted at the N-terminal end, up to amino acid 350, led to a positive result (Figure 1e ). These data indicate that the MCM7-binding domain of INT6 is located between amino acids 351 and 395. This region of INT6 corresponds to the C-terminal moiety of the PCI domain. Similarly, various pieces of the C-terminal domain of MCM7 were associated with the GAL4-activation domain and tested by the twohybrid assay with INT6 as bait. On the N-terminal side, deletion from amino acid 579-610 led to loss of the interaction (Figure 1f ), whereas at the C-terminal end removal of amino acid 595-575 impaired the interaction (Figure 1f ). These results show that the part of MCM7 mediating the interaction with INT6 is located between amino acids 579 and 595, outside the MCM box. To confirm that this short piece of MCM7 is able to bind INT6, GST pull-down experiments were performed with a protein associating GST with amino acids 570-601 of MCM7. Either wild-type GST or GST fused to this peptide of MCM7 was expressed in bacteria and coupled with glutathione agarose beads. An extract of Jurkat cells was loaded on columns made with these beads. After being washed with a buffer including 1 M NaCl, proteins were eluted from the column with glutathione and analysed by immunoblot using an antibody directed against INT6. A signal corresponding to INT6 was clearly detected with beads including the MCM7 peptide, but not with those corresponding to GST alone (Figure 1g , compare lanes 3 and 2). The same experiment was performed with INT6 expressed in bacteria and purified to homogeneity. As before INT6 was seen with the beads bearing the MCM7 peptide, but not with the control beads (Figure 1h, lanes 3 and 2) . Taken together, these results show that a short peptide of MCM7, which includes the 579-595 domain, is able to bind INT6. Since this interaction was observed with purified recombinant proteins, it is direct and not dependent on the presence of other proteins. These data establish that the interaction between INT6 and MCM7 is a direct protein-protein interaction, which relies on specific domains of limited size.
MCM7 is modified by polyubiquitylation
As INT6 has been functionally involved in protein degradation, we investigated the possibility that it acts on MCM7 stability. We first tested whether MCM7 can be polyubiquitylated. In agreement with a previous report (Kuhne and Banks, 1998) , when endogenous MCM7 was immunoprecipitated and analysed using an antibody recognizing polyubiquitylated proteins, a weak smear of bands above the position of unmodified MCM7 was observed and its intensity was reinforced by a proteasome inhibitor treatment (Figure 2a , compare lanes 2 and 4), strongly suggesting that endogenous MCM7 is polyubiquitylated and that these polyubiquitylated forms are processed by the proteasome. Polyubiquitylation of endogenous MCM7 was also indicated by transfecting cells with a vector encoding ubiquitin fused at its N terminus to the FLAG tag, an approach which allows a more sensitive visualization of MCM7 modification ( Figure 2b , lane 2). It was further analysed whether this polyubiquitylation was specific of MCM7 or also intervenes with other MCMs. Cells were transfected with expression vectors for MCM4, MCM6 or MCM7 fused at their N terminus to the HA epitope, along with a plasmid producing FLAGubiquitin. In agreement with previous results, immunoprecipitation using the HA antibody showed that MCM7 is polyubiquitylated, but this was not seen for MCM4 and MCM6 (Figure 2c) .
In mammalian cells, MCM7 is tightly associated with chromatin in G1 and progressively unloaded during S phase as replication proceeds (Fujita et al., 1996) . Hence, we examined whether ubiquitylation affects distribution of MCM7 between nucleoplasm and chromatin. For this, 293T cells transfected with vectors expressing HA-ubiquitin and FLAG-MCM7 were separated into non-chromatin and chromatin fractions. Fractionation was controlled by detection of origin recognition complex subunit 2 (ORC2) constitutively associated with chromatin, and also of ribonucleotide reductase polypeptide M2 (RRM2) localized within the cytoplasm (Figure 2d , lower panels). Overexpression of ubiquitin augmented the signal corresponding to tagged MCM7 in the chromatin fraction (Figure 2d , compare lanes 6 and 7), and high-molecular-weight bands corresponding to polyubiquitylated MCM7 were specifically detected in this fraction (Figure 2d , compare lanes 3 and 7). Hence, polyubiquitylated forms of MCM7 are associated with chromatin, suggesting that this modification targets DNA-bound MCM7. Interestingly, INT6 overexpression was found to increase both unmodified and polyubiquinated forms of MCM7 in the chromatin fraction (Figure 2d , compare lanes 7 and 8).
Proteasome inhibition augments association of INT6 with MCM7
We next examined whether ubiquitylation of MCM7 affects its interaction with INT6. As MG132 treatment increases the amount of MCM7 polyubiquitylated forms (Figure 2a unmodified and polyubiquitylated MCM7 within the nucleus, either associated with chromatin or present in the nucleoplasm. The fact that association of the two proteins is strengthened following proteasome inhibition suggests that INT6 interacts with MCM7 species that are subjected to proteasomal processing. Hence, we studied further if INT6 may affect MCM7 stability.
Stabilization of MCM7 by INT6
As a first attempt to see whether INT6 regulates the half-life of MCM7, pulse-chase experiments were performed in 293T cells. These experiments showed that raising the intracellular amount of INT6 reduces the decrease in radiolabeled endogenous MCM7 as a function of time (Figure 4a ). Stability of MCM6 or RRM2 was marginally modified by INT6 overexpression (Supplementary Figure S2) . In agreement with a stabilizing role of INT6 overexpression, an increase in polyubiquitylated MCM7 was observed when the intracellular amount of INT6 was raised (Figure 4b , compare lanes 7 and 8). This was likely to result from hindered degradation of these polyubiquitylated forms. To confirm that INT6 acts on the stability of MCM7, we assessed the consequence of its suppression by RNA interference. Immunoblot analysis of extracts obtained from cells treated with the INT6 siRNAs showed a lower MCM7 signal (Figure 4c , compare lanes 3 and 4 with lanes 1 and 2). That the same outcome was obtained with two different siRNA duplexes indicates that it results from silencing of INT6 and not from an off-target effect. Such decreased protein amounts were not observed for MCM4 or HSPC021 (Figure 4c) , and for MCM3, a slight decrease was seen but only with one INT6 siRNA couple. It was next examined which pool of MCM7 was decreased by INT6 silencing. Cells transfected with control, INT6 or MCM7 siRNAs were separated in non-chromatin and chromatin fractions. When INT6 was silenced, a decreased MCM7 immunoreactivity was apparent in the chromatin fraction, but not in the non-chromatin extract (Figure 4d 1-4) and chromatin (c, lanes 5-8) fractions, which were analysed by immunoblot using a FLAG antibody (top panel). These extracts were also analysed with antibodies directed against ORC2 (middle panel) or RRM2 (bottom panel) to control the fractionation process.
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We have reported previously that silencing of INT6 in HeLa cells does not modify duration of the G1 phase (Morris and Jalinot, 2005) , thus providing an indication that the onset of DNA replication is not altered. To test possible defects during the replication process, we first measured the stability of MCM7 in control or INT6-depleted cells synchronized at the G1/S transition by a double thymidine block (Figure 5a) . A much more rapid degradation of MCM7 during S phase was observed following INT6 silencing: MCM7 half-life was calculated to 2.9 h in INT6-depleted cells versus 8.2 h in control cells (Figure 5b ). Such an increased degradation was not found for MCM6 or RRM2 (Supplementary Figure S3) .
It is known that MCM proteins start to dissociate from chromatin during S phase (Fujita et al., 1996) . Thus, we investigated whether this dissociation process was affected by INT6 knockdown. HeLa cells synchronized by a double thymidine block were harvested at different times during S and G2 phases and fractionated into chromatin and non-chromatin extracts. Immunoblots from these fractions showed that the levels of MCM7 and MCM6 into chromatin fractions decline progressively and are very weak when cells enter G2, that is 6-8 h after block release (Figure 5c ). Interestingly, when INT6 was silenced, the progressive decline was accelerated and a lower amount of MCM7 was associated with chromatin during S phase (Figure 5c , lanes 7 and 8, compare MCM7 signals in chromatin fraction at times 2 and 4 h from control and INT6 siRNA-transfected cells). Quantitation of this effect is shown in Figure 5d . These results suggest that stabilization by INT6 of the MCM7 polyubiquitylated forms on chromatin slows down their removal from this compartment and that this removal process is dependent on proteasome activity. To evaluate this point, we analysed how blockade of the proteasome with MG132 affects MCM7 chromatin unloading. HeLa cells synchronized by a double thymidine block were treated or not with MG132 1 h after block release, collected at different times and fractionated into non-chromatin and chromatin fractions. In untreated cells, MCM7 unloading took place as expected, whereas in MG132-treated cells it was strongly inhibited (Figure 6a lanes 5-8; Figure 6b ). Cell cycle analysis showed that this was not due to an arrest of these cells in G1/S. Indeed at the 3 h time point, no modification in the cell cycle distribution was observed following MG132 treatment, although a clear inhibitory effect on unloading was visible (Figure 6b) . At later times, MG132 slows down progression of cells towards G2/M. Interestingly, at the 6 and 9 h time points, a long exposure of the immunoblot carried out with the antibody to MCM7 showed a smear of high molecular weight bands in the chromatin fraction corresponding to polyubiquitylated MCM7. This smear was not visible at shorter time points or in the absence of MG132 treatment (data not shown). These observations thus support the notion that 
INT6 regulates MCM7 stability
S Buchsbaum et al MCM7 unloading from chromatin during S phase depends on processing of its polyubiquitylated forms by the proteasome.
INT6 depletion activates expression of mcm7
The MCM7 level is almost constant during cycling of control cells, whereas in INT6-silenced cells it decreases during S phase and then re-increases during G2 ( Figure 7a ). As INT6 is associated with the eIF3 translation initiation factor, we investigated if its depletion affected mcm7 mRNA translation. So we analysed incorporation of radiolabeled methionine into MCM7 as a function of time in mock-or INT6 siRNAtransfected cells, but we did not find any effect of INT6 silencing (Supplementary Figure S4a) . The distribution of the mcm7 mRNA between cytoplasm and nucleus was also observed to be insensitive to INT6 depletion (Supplementary Figure S4b) . Finally, it was also observed that INT6 suppression did not alter the presence of mcm7 mRNA in polysomes (Supplementary Figure S4c) . We concluded from these observations that INT6 depletion affects neither nuclear export nor translation of the mcm7 mRNA. In yeast, MCM7 is able to inhibit its own transcription (Fitch et al., 2003) . So we hypothesized that reduced abundance of MCM7 in S phase of INT6-silenced cells may induce higher mcm7 transcription, leading to the re-increase in MCM7 amount observed in G2. Hence, mcm4, mcm6 and mcm7 mRNAs were quantified in cells synchronized at different times in S and G2 phases. This showed that only mcm7 mRNA increases during S phase of INT6-silenced cells (Figure 7b) , the time at which MCM7 protein appears the most unstable. This indicates that reduction in chromatin-bound MCM7 triggers re-expression of its gene, which is likely to compensate in G2 the loss of MCM7 in S phase due to In6 depletion.
INT6 depletion causes a DNA replication defect
Finally, we examined if the effects of INT6 depletion observed for MCM7 correlate with DNA replication alterations. DNA synthesis was monitored by incorporation of radiolabeled thymidine in cells transfected with control, MCM7 and INT6 siRNAs (Figure 8b and c). As expected, MCM7 silencing slows down thymidine incorporation which remains 40% lower at the end of S phase (Figure 8a ). INT6 silencing has an even stronger effect, showing a 60% diminished thymidine incorporation (Figure 8a ). This indicates that MCM7, but also INT6 silencing causes DNA replication defects. We anticipated that MCM7 depletion impedes activity of the whole-MCM complex, causing replication stress, and in fact, chromatin-bound RPA increased after mcm7 siRNA transfection (Figure 9a ). INT6 silencing also led to such an increase in chromatin-bound RPA, whereas chromatin-bound MCM7 was reduced, as already noticed (Figure 4d ). We also analysed distribution of claspin, another protein of which association with replication forks is increased in case of replication stress (Lin et al., 2004; Sar et al., 2004) . As for RPA, INT6 silencing increases its abundance on chromatin, in a more efficient way than MCM7 silencing (Figure 9b ). These observations support the notion that INT6 contibutes to DNA replication, its depletion leading to clear signs of replication fork stress.
Discussion
Regulation of MCM7 by polyubiquitylation
To ensure genome stability during replication, molecular mechanisms have evolved to avoid non-replicated or overreplicated DNA regions. The MCM complex, recruited onto origins during G1, acts in this 
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S Buchsbaum et al surveillance by allowing only one round of replication per cell cycle. MCM7 contributes in various aspects of the MCM complex functioning and is most likely regulated by post-translational modifications (Wang et al., 2000) . In agreement with the observations of Kuhne and Banks (1998) , we observed that MCM7 can be polyubiquitylated and that the resulting modified forms are processed by the proteasome, as they increase when cells are treated with an inhibitor of this proteolytic complex. Interestingly, MCM7 polyubiquitylated forms were associated with chromatin, suggesting they can be degraded when still associated with DNA. Moreover, we show that MCM7 is less stable in S phase as compared with G2/M. From these observations, we propose that removal of MCM7 from chromatin during S phase results from its degradation. This notion is supported by the strong inhibition of MCM7 unloading observed after proteasome blockade by MG132 treatment in synchronized cells. It has been shown that several MCM complexes are loaded per replication origin (Blow and Dutta, 2005) and, considering the limited helicase activity of the MCM complex (Ishimi, 1997; Lee and Hurwitz, 2001) , one can speculate that a single MCM complex separate both DNA strands on a limited distance. At a certain point the MCM complex would be disassembled, possibly as a consequence of polyubiquitylated MCM7 degradation. Another MCM complex would then exert the helicase activity on a new portion of DNA. At late stages, DNA unwinding is likely to rely on MCM8, another member of the MCM family (Maiorano et al., 2005) . Such a sequential intervention of numerous MCM complexes and their progressive disassembly could explain gradual removal of the MCM proteins from chromatin in the course of DNA replication. With its ubiquitin-like (UbL) and ubiquitin-associated domains (UBA), Rad23 can bind both the proteasome and ubiquitylated proteins, thus strongly inhibiting their degradation, at least in some instances (Raasi and Pickart, 2003; Hwang et al., 2005) . Another interesting example is the adenovirus E1a protein which interacts with the Rpn1, Rpt2 and Rpt6 subunits of the proteasome 19S regulatory particle and protects p53 from degradation, likely by impairing processing of its polyubiquitylated forms by the proteasome (Zhang et al., 2004) . As INT6 interacts with Rpt4 (Hoareau Alves et al., 2002) and Rpn5 (Yen et al., 2003) , it might similarly inhibit the processing of MCM7 polyubiquitylated forms by hindering their association with the proteasome. Our results suggest that this protective effect can occur when INT6 and MCM7 are on DNA, because they interact in chromatin extracts. This interaction was also observed in a nucleoplasmic extract, but not in a cytoplasmic extract containing abundant amounts of both proteins. In this latter case, binding of INT6 to other proteins (as eIF3 subunits) is likely to preclude its association with MCM7. Collectively, our observations suggest that INT6 restrains the increased degradation of MCM7 occurring during DNA replication by protecting its polyubiquitylated derivatives from the proteasome activity.
INT6 increases MCM7 stability
Regulation of MCM7 amount in response to its destabilization
The total amount of MCM7 was reduced in S phase of INT6-silenced cells, due to its decreased half-life, but normal levels were recovered in late G2. Unexpectedly, this fluctuation appeared to result not from an effect of INT6 silencing on MCM7 mRNA translation but from an increase in the amount of MCM7 mRNA that occurred mainly during S phase. In yeast, Mcm7 inhibits its own expression by binding to its promoter in association with Mcm1 (Fitch et al., 2003) . A likely explanation to the increased transcription of mcm7 in INT6-silenced cells is that MCM7 also negatively regulates its own expression in mammalian cells. Its destabilization accelerates its removal from chromatin and this would enhance transcription of its gene, thereby constituting a feedback loop that would normalize the amount of MCM7 in G2 as the protein is more stable in this phase. Concerning the model previously evoked linking removal of MCM7 from chromatin to its degradation, such a retro control also explains why its level remains nearly constant during cell cycle progression despite its lower stability in S phase.
Alteration of genomic integrity by modification of DNA replication factors stability Examination of thymidine incorporation kinetics in MCM7 and INT6-silenced cells showed a similar alteration, although stronger in the latter case, possibly due to an effect on the stability of other proteins participating to replication. Alternatively, premature MCM7 unloading might impede replication more profoundly than a reduction in its total amount. This experiment suggests that when INT6 is silenced, cells fail to complete replication. Defective DNA replication was also supported by the observed increase in the chromatin-bound pool of RPA and claspin. Loss of MCM7 at early steps of replication is likely to impair helicase activity of the MCM complex , causing replication fork stress. In future studies it will be interesting to address the question of the relationship between this defective replication and mitotic abnormalities.
In conclusion, our results show that INT6 interacts with polyubiquitylated forms of MCM7 and controls their degradation rate. This activity ensures accurate and complete DNA replication, thereby likely contributing to genome stability. Alteration of this process by INT6 silencing would lead to genome instability, offering an attractive molecular explanation to the results of Buttitta et al. (2005) establishing INT6 reduced expression as a poor prognosis indicator for non-small cell lung carcinomas.
Materials and methods
Constructs pSGM-MCM7 and pSGF-MCM7 were generated by amplifying with appropriate primers the MCM7 coding sequence from a plasmid including the complete human MCM7 ORF kindly provided by M Fujita (Fujita et al., 1996) . Polymerase chain reaction products were inserted between XhoI and BglII sites of pSGM or XhoI filled in and BamHI sites of pSGF vector which are pSG5 derivatives including the MYC or FLAG epitope. pSGHA-MCM4, pSGHA-MCM6 and pSGHA-MCM7 were generated by inserting the MCM4, MCM6 and MCM7 coding sequences, respectively, in pSG-HA, a pSG5 derivative including the HA epitope.
pSGF-Ub was generated by amplifying and inserting between BamHI and XhoI sites of pSGF the human ubiquitin coding sequence. pSG-HA-Ub, which expresses human ubiquitin fused at its N terminus with three HA epitopes, was generated by inserting the HindIII BamHI restriction fragment of plasmid pcDNA-HA-Ub, kindly provided by V Dixit (Zhou et al., 2004) , between the HindIII and BglII restriction sites of pTL1.
Cell culture and transfection
Jurkat cells were cultured in RPMI 1640 medium with 10% fetal calf serum (FCS) (Sigma, St Louis, MO, USA), 100 units/ ml penicillin and 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA) at 371C in a 10% CO 2 -humidified atmosphere. HeLa, 293T and COS7 cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) with 10% FCS (Invitrogen) and 100 units/ml penicillin and 100 mg/ml streptomycin at 371C in a 5% CO 2 -humidified atmosphere. For transfection, FCS concentration was reduced to 5% and antibiotics were omitted for siRNA transfection, which was performed using the Lipofectamine 2000 reagent (Invitrogen). INT6 and control siRNA duplexes have been described previously (Morris and Jalinot, 2005) . MCM7 siRNAs corresponded to nucleotide 247-265 with respect to the initiation codon on the sense strand of the mcm7 mRNA, with addition of two T residues at each 3 0 end. Expression vectors were transfected using the calcium phosphate precipitation method. To achieve inhibition of the proteasome, MG132 (Sigma) was added at 10 or 20 mM. For G1/S synchronization, 2.5 mM of thymidine (Sigma) was added for 18 h, then removed for 10 h and added at the same concentration for 14 h. For pulse-chase experiments, cells were incubated for a 2-h pulse in culture medium with 150 mCi/ml 35 S-methionine (Amersham Biosciences, Bucks, UK), washed, incubated for chase in DMEM 5% FCS and finally washed with phosphate-buffered saline (PBS) and frozen. For thymidine incorporation assay, cells were incubated in culture medium containing 10 mCi/ml 3 H-methyl thymidine (Amersham Biosciences), then washed twice with cold 10% trichloroacetic acid and lysed in 0.2 N NaOH. Radioactivity of lysates was counted in a Wallac apparatus with 3 H mode by adding 30 ml of lysate in 1 ml of Supermix (PerkinElmer, Waltham, MA, USA). Values in cpm were normalized with respect to protein concentrations which were quantified with the DC protein assay kit (Bio-Rad, Hercules, CA, USA).
Cell fractionation
HeLa or 293T cells were lysed in 300 ml buffer F (10 mM Hepes pH 7.5, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl 2 , 0.5% NP40, 1 mM DTT, 5 mM iodoacetamide) during a 20 min incubation on ice with resuspension every 5 min. Chromatin was isolated by a centrifugation of 3 min at 350 g, washed three times and sonicated in 300 ml of buffer F.
Immunoprecipitation and immunoblot
To analyse interaction between endogenous INT6 and MCM7, 1 Â 10 7 HeLa or Jurkat cells were lysed in 300 ml of buffer N (50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 0.05% NP-40, 0.5 mM TCEP (Sigma), 0.5 mM Pefabloc (Roche, Basel, Switzerland)) by four 10 s sonication time using a Bioruptor system (Diagenode, Lie`ge, Belgium) and centrifuged at 10 000 g for 10 min at 41C. Lysates were precleared by incubation with 40 ml of protein A-agarose beads for 1 h and supernatants were incubated overnight at 41C with a mix of two INT6 antisera (C-20 and N-19) . About 80 ml of protein A-agarose beads were then added for 1 h, washed three times for 10 min and resuspended in 20 ml of Â 2 SDS sample buffer. For all other immunoprecipitations, cells were lysed in 300 ml RIPA buffer (Harlow and Lane, 1988) containing 1 mM iodoacetamide (Sigma) and centrifuged for 15 min at 14 000 r.p.m. Supernatants adjusted to equal protein concentrations were incubated for 1 h 30 with antibodies diluted 1:250. About 40 ml of protein A-beads were then added to the mixes which were further incubated for an additional hour. Beads were collected by centrifugation at 2000 r.p.m. for 2 min and washed three times in lysis buffer. Proteins were eluted in Â 2 SDS sample buffer at 801C for 10 min. After separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), proteins were transferred to PVDF membrane (Amersham Biosciences). For immunoblot, primary antibodies were diluted 1:1000 or as indicated by the manufacturer and detection was performed by chemiluminescence.
The antibody against MCM7 was obtained by immunization of rabbits with a peptide corresponding to the N-terminal 20 amino acids of MCM7 coupled to a carrier protein.
Antibodies against MCM3 and MCM4 were kindly provided by H Kimura (Kimura et al., 1995) , those against MCM6 by R Knippers (Holthoff et al., 1998) and RRM2 by T Kinsella (Kuo and Kinsella, 1997) . The C-20 rabbit polyclonal antibody to INT6 has been described previously (MorrisDesbois et al., 1999) . Following antibodies were purchased: polyubiquinated proteins (P4D1, Cell Signaling Technology, Danvers, MA, USA), MYC (clone 9E10, Sigma), FLAG (clone M2, Sigma), b-actin (Sigma), ORC2 (#559266, BD Biosciences, San Jose, CA, USA), RPA p70 subunit (#NA13, Oncogene, Merck, Darmstadt, Germany), claspin (#NB100-247, Novus Biologicals, Littleton, CO, USA) and HA (clone 12CA5, Roche).
Real-time quantitative RT-PCR Total RNAs were extracted from frozen cells using the RNeasy mini-kit (Qiagen, Hilden, Germany). For cytoplasmic and nuclear RNAs, cells were harvested, washed in PBS and incubated for 5 min on ice in buffer R (10 mM Tris-HCl pH 7.8, 10 mM NaCl, 2 mM MgCl2, 5 mM DTT). NP40 was then added at 0.5% and incubation pursued for 5 min. Nuclei were centrifuged for 4 min at 1300 g and RNAs from cytoplasmic supernatant precipitated with ethanol. Nuclei and cytoplasmic RNAs were then extracted using the RNeasy mini-kit. One step real-time-PCR reactions were performed using the QuantiTect SYBR Green RT-PCR kit (Qiagen) and the LightCycler apparatus (Roche). Sequences of sense and antisense primers (designed using the Primer3 
